Hims & Hers Health(DE:82W)
€18.08+1.10 (+6.48%)
DE:82W
Hims & Hers Health stock forecast
€18.08
At close:+1.10 (+6.48%)
Hims & Hers Health (82W) Stock Forecast & Price Target
38 Followers
82W Analyst Ratings
Hold
3Buy9Hold0Sell
Based on 12 analysts giving stock ratings to Hims & Hers Health in the past 3 months
82W Stock 12 Month Forecast
Average Price Target
€26.16▲(44.71% Upside)Based on 12 Wall Street analysts offering 12 month price targets for Hims & Hers Health in the last 3 months. The average price target is EUR 26.16 with a high forecast of EUR 35.81 and a low forecast of EUR 21.49. The average price target represents a 44.71% change from the last price of EUR 18.08.
Past 12 Months12 Month ForecastJan2026Oct2026
High€35.81
Average€26.16
Low€21.49
Highest Price TargetHighest€35.81Average Price Target€26.16Lowest Price TargetLowest€21.49
Detailed List of Analyst Forecasts
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Justin Patterson | KeyBanc | ― | hold | ― | Reiterated | 11/11/26 | ||
| Glen Santangelo | Barclays | €31.34 | buy | 73.33%Upside | Reiterated | 11/10/26 | ||
| Bryan Smilek | J.P. Morgan | €28.65→€21.49 | hold | 18.85%Upside | Reiterated | 11/10/26 | ||
| Maria Ripps | Canaccord Genuity | €35.81 | buy | 98.09%Upside | Reiterated | 11/10/26 | ||
| Ryan MacDonald | Needham | €37.60→€28.65 | buy | 58.47%Upside | Reiterated | 11/10/26 | ||
| Mark Mahaney | Evercore ISI | €21.49→€24.17 | hold | 33.71%Upside | Reiterated | 11/10/26 | ||
| Craig Hettenbach | Morgan Stanley | €25.07→€22.38 | hold | 23.80%Upside | Assigned | 11/10/26 | ||
| Brian Tanquilut | Jefferies | €27.76→€21.49 | hold | 18.85%Upside | Reiterated | 11/10/26 | ||
| Michael Cherny | Leerink Partners | €26.86→€21.49 | hold | 18.85%Upside | Reiterated | 11/10/26 | ||
| Allen Lutz | Bank of America Securities | ― | hold | ― | Reiterated | 11/10/26 | ||
| David Larsen | BTIG | ― | hold | ― | Reiterated | 11/09/26 | ||
| Jailendra Singh | Truist Financial | €28.65 | hold | 58.47%Upside | Reiterated | 09/11/26 | ||
| Daniel Grosslight | Citi | €31.34→€29.55 | hold | 63.42%Upside | Reiterated | 08/12/26 | ||
| Jonna Kim | TD Cowen | €22.38→€26.86 | hold | 48.56%Upside | Assigned | 08/11/26 | ||
| George Hill | Deutsche Bank | €22.38→€23.28 | hold | 28.76%Upside | Assigned | 08/11/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Justin PattersonKeyBanc | HoldReiterated | 11/11/26 | ― | ||
| Glen SantangeloBarclays | BuyReiterated€31.34 | 11/10/26 | 73.33%Upside | ||
| Bryan SmilekJ.P. Morgan | HoldReiterated€28.65→€21.49 | 11/10/26 | 18.85%Upside | ||
| Maria RippsCanaccord Genuity | BuyReiterated€35.81 | 11/10/26 | 98.09%Upside | ||
| Ryan MacDonaldNeedham | BuyReiterated€37.60→€28.65 | 11/10/26 | 58.47%Upside | ||
| Mark MahaneyEvercore ISI | HoldReiterated€21.49→€24.17 | 11/10/26 | 33.71%Upside | ||
| Craig HettenbachMorgan Stanley | HoldAssigned€25.07→€22.38 | 11/10/26 | 23.80%Upside | ||
| Brian TanquilutJefferies | HoldReiterated€27.76→€21.49 | 11/10/26 | 18.85%Upside | ||
| Michael ChernyLeerink Partners | HoldReiterated€26.86→€21.49 | 11/10/26 | 18.85%Upside | ||
| Allen LutzBank of America Securities | HoldReiterated | 11/10/26 | ― | ||
| David LarsenBTIG | HoldReiterated | 11/09/26 | ― | ||
| Jailendra SinghTruist Financial | HoldReiterated€28.65 | 09/11/26 | 58.47%Upside | ||
| Daniel GrosslightCiti | HoldReiterated€31.34→€29.55 | 08/12/26 | 63.42%Upside | ||
| Jonna KimTD Cowen | HoldAssigned€22.38→€26.86 | 08/11/26 | 48.56%Upside | ||
| George HillDeutsche Bank | HoldAssigned€22.38→€23.28 | 08/11/26 | 28.76%Upside |
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Best Analysts Covering Hims & Hers Health
3 Months
Success Rate11/16 ratings generated profit
69%
Average Return
+21.88%
Copying Maria Ripps's trades and holding each position for 3 Months would result in 68.75% of your transactions generating a profit, with an average return of +21.88% per trade.
1 Year
Success Rate8/14 ratings generated profit
57%
Average Return
+19.16%
Copying Glen Santangelo's trades and holding each position for 1 Year would result in 57.14% of your transactions generating a profit, with an average return of +19.16% per trade.
2 Years
Success Rate8/14 ratings generated profit
57%
Average Return
+19.97%
Copying Glen Santangelo's trades and holding each position for 2 Years would result in 57.14% of your transactions generating a profit, with an average return of +19.97% per trade.
82W Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 3 |
| Buy | 10 | 9 | 7 | 5 | 1 |
| Hold | 25 | 22 | 27 | 18 | 18 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 35 | 31 | 34 | 23 | 22 |
In the current month, 82W has received 4 Buy Ratings, 18 Hold Ratings, and 0 Sell Ratings. 82W average Analyst price target in the past 3 months is 26.16.
82W Financial Forecast
High€0.11
Consensus€-0.01
Low€-0.12
82W Earnings Forecast
Next quarter’s earnings estimate for 82W is -EUR 0.01 with a range of -EUR 0.12 to EUR 0.11. The previous quarter’s EPS was -EUR 0.13. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
High€942M
Consensus€814M
Low€794M
82W Sales Forecast
Next quarter’s sales forecast for 82W is EUR 813.87M with a range of EUR 793.94M to EUR 942.27M. The previous quarter’s sales results were EUR 802.39M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
82W Stock Forecast FAQ
What is DE:82W’s average 12-month price target, according to analysts?
Based on analyst ratings, Hims & Hers Health’s 12-month average price target is €26.16.
What is DE:82W’s upside potential, based on the analysts’ average price target?
Hims & Hers Health has 44.71% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Hims & Hers Health a Buy, Sell or Hold?
Hims & Hers Health has a consensus rating of Hold, which is based on 3 buy ratings, 9 hold ratings and 0 sell ratings.
What is Hims & Hers Health’s share price target?
The average share price target for Hims & Hers Health is €26.16. This is based on 12 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is €35.81, and the lowest forecast is €21.49. The average share price target represents a 44.71% increase from the current price of €18.08.
What do analysts say about Hims & Hers Health?
Hims & Hers Health’s analyst rating consensus is a Hold. This is based on the ratings of 12 Wall Street analysts.
How can I buy shares of Hims & Hers Health?
To buy shares of DE:82W, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
